# Abbott Laboratories (ABT) — Q4-2022 Earnings Results

**Report date:** 2023-01-25 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABT/earnings/Q4-2022

## Post-Earnings Brief

### Headline

Abbott Laboratories Beats on EPS, Stock Down 1.36%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.03 | N/A | +14.32% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record, and the analysis is based solely on numerical results.

### Guidance Changes

No forward guidance data is available for this quarter.

### What It Means

Abbott Laboratories reported better-than-expected earnings per share, beating estimates by 14.32%. However, the stock reacted negatively, declining by 1.36%. The lack of revenue data and guidance may have contributed to investor uncertainty.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABT/earnings/Q4-2022_